Abstract
We measured growth hormone (GH), insulin-like growth factor-I (IGF-I), and both total and glycosylated prolactin (PRL) levels in 131 blood samples obtained by cordocentesis in normal and abnormal fetuses from 19 to 40 weeks of gestation. In normal fetuses, IGF-I and PRL levels showed a positive correlation and GH a negative correlation with gestational age. A negative relation between GH and IGF-I levels was observed, while PRL did not show any correlation with both GH and IGF-I concentrations. IGF-I increased from 5.6±3 (at 19–22 weeks) to 10.7±5 nmol/l at term; GH decreased from 31±10 to 7.7±4 μg/l and PRL increased from 16±18 to 139±76 μg/l. Glycosylated PRL accounted for about 15% of total PRL, a value similar to that found in normal adults. In 27 fetuses of 27–37 weeks with intra-uterine growth retardation, GH and PRL levels were higher and IGF-I levels lower than in normal fetuses matched for week of gestation. In 8 anencephalic fetuses of 19–26 weeks of gestation, both GH and IGF-I levels were lower, and PRL levels were higher than in matched controls. Altogether these data support the views that a) both GH and PRL secretion are under the hypothalamic control during fetal development, b) the serum GH decrease from midgestation to the end of pregnancy is mediated by the negative feed-back mechanism of increasing IGF-I levels and c) IGF-I production is mainly regulated by fuel supply and only partially by GH.
Similar content being viewed by others
References
Wang H.S., Chard T. The role of insulin-like growth factor-I and insulin-like growth factor-binding protein-I in the control of human fetal growth. J. Endocrinol. 132: 11,1992.
Ashton I.K., Zapf J., Einschenk I., MacKenzie I.Z. Insulin-like growth factor (IGF) I and II in human foetal plasma and relationship to gestational age and foetal size during midpregnancy. Acta Endocrinol. (Copenh.) 110: 558, 1985.
Sara V.T., Hall K., Misaki M., Fryklund L., Christensen N., Wetterberg L. Ontogenesis of somatomedin and insulin receptors in the human fetus. J. Clin. Invest. 71: 1084, 1983.
Gluckman P.D., Grumbach M.M., Kaplan S.L. The neuroendocrine regulation and function of growth hormone and prolactin in the mammalian fetus. Endocr. Rev. 2: 363, 1981.
Kaplan S.L., Grumbach M.M., Shepard T.H. The ontogenesis of human fetal hormones. I. Growth hormone and insulin. J. Clin. Invest. 51: 3080, 1972.
Mulchahey J.J., Di Blasio A.M., Martin M.C., Blumenfeld Z., Jaffe R.B. Hormone production and peptide regulation of the human fetal pituitary gland. Endocr. Rev. 8: 406, 1987.
Hill D.J., Freemark M., Strain A.J., Handwerger S., Milner R.D. Placental lactogen and growth hormone receptors in human fetal tissues: relationship to fetal plasma hPL concentrations and fetal growth. J. Clin. Endocrinol. Metab. 66: 1283, 1988.
Massa G., de Zegher F., Vanderschueren-Lodeweyckx M. Serum growth hormone-binding proteins in the human fetus and infant. Pediatr. Res. 32: 69, 1992
Silbergeld A., Lazar L., Erster B., Keret R., Tepper R., Laron Z. Serum growth hormone binding protein activity in healthy neonates, children and young adults: correlation with age, height and weight. Clin. Endocrinol. (Oxf.) 31: 295, 1989
Amit T., Barkey R.J., Youdim M.B.H., Hochberg Z. A new and convenient assay of growth hormone binding protein activity in human serum. J. Clin. Endocrinol. Metab. 71: 474, 1990
Wallis M. The molecular evolution of pituitary growth hormone, prolactin and placental lactogen: a protein family showing variable rates of evolution. J. Mol. Evol. 17: 10, 1981
Bucher H., Zapf J., Torresani T., Prader A., Froesch E.R., and Illig R. Insulin-like growth factors I and II, prolactin and insulin in 19 growth-hormone deficient children with excessive, normal or decreased longitudinal growth after operation for craniopharyngioma. N. Engl. J. Med. 309: 1142, 1983
Daffos F., Capella-Pavloski M., Forester F. Fetal blood sampling during pregnancy with use of a needle guided by ultrasound: a study of 606 consecutive cases. Am. J. Obstet. Gynecol. 153: 655, 1985
Beck-Peccoz P., Padmanabhan V., Baggiani A.M., Cortelazzi D., Buscaglia M., Medri G., Marconi A.M., Pardi G., Beitens I.Z. Maturation of hypothalamic-pituitary-gonadal function in normal human fetuses: circulating levels of gonadotropins, their common α-subunit and free testosterone, and discrepancy between immunological and biological activities of circulating follicle-stimulating hormone. J. Clin. Endocrinol. Metab. 73: 525, 1991.
Pardi G., Cetin I., Marconi A.M., Lanfranchi A., Bozzetti P., Ferrazzi E., Buscaglia M., Battaglia F.C. Diagnostic value of blood sampling in fetuses with growth retardation. N. Engl. J. Med. 328: 692, 1993.
Gluckman P.D., Johnson-Barret J.J., Butler J.H., Edgar B.W., Gunn T.R. Studies on insulin-like growth factor I and II by specific radioligand assays in umbelical cord blood. Clin. Endocrinol. (Oxf.) 19: 405, 1983.
Bennett A., Wilson D.M., Liu F., Nagashima R., Rosenfeld R.G., Hintz R.L. Levels of insulin-like growth factors I and II in human cord blood. J. Clin. Endocrnol. Metab. 57: 609,1983.
Thieriot-Prevost G., Daffos F., Forestier F., Job J.C. Serum somatomedin C., bioassayable growth promoting activity (thymidine activity), and transferrin in human fetuses: in utero study. Pediatr. Res. 20: 71, 1986.
Lassarre C., Hardouin S., Daffos F., Forestier F., Frankenne F., Binoux M. Serum insulin-like growth factor binding proteins in the human fetus. Relationship with growth in normal subjects and in subjects with intrauterine growth retardation. Pediatr. Res. 29: 219, 1991.
Celniker A.C., Chen A.B., Wert R.M. Jr., Sherman B.M. Variability in the quantitation of circulating growth hormone using commercial immunoassays. J. Clin. Endocrinol. Metab. 68: 469, 1989.
Salardi S., Orsini L.F., Cacciari E., Righetti F., Donati S., Mandini M., Cicognani A., Bovicelli L. Growth hormone, insulin-like growth factor I, insulin and C-peptide during human fetal life: in-utero study. Clin. Endocrinol. (Oxf.) 34: 187, 1991.
Goodyer C.G., Marcovitz S., Hardy J., Lefebvre Y., Guyda H.J., Posner B.I. Effect of insulin-like growth factors on human foetal, adult normal and tumor pituitary function in tissue culture. Acta Endocrinol.(Copenh.) 112: 49, 1986.
De Zegher F., Daaboul J., Grumbach M.M., Kaplan S.L. Hormone ontogeny in the ovine fetus and neonate. XXII. The effect of somatostatin on the growth hormone (GH) response to GH-releasing factor. Endocrinology 124: 1114, 1989.
Gluckman P.D. Intrauterine growth retardation: future research directions. Acta Pediatr. Suppl. 388: 96, 1993.
Bassett N.S., Oliver M.H., Breier B.H., Gluckman P.D. The effect of maternal starvation on plasma insulin-like growth factor I concentrations in the late gestation ovine fetus. Pediatr. Res. 27: 401, 1990.
Straus D.S., Ooi G.T., Orlowski C.C., Rechler M.M. Expression of the genes for insulin-like growth factor-I (IGF-I), IGF-II, and IGF-binding proteins-1 and - 2 in fetal rat under conditions of intrauterine growth retardation caused by maternal fasting. Endocrinology 128: 518, 1991.
Iwamoto H.S., Murray M.A., Chernausek S.D. Effects of acute hypoxemia on insulin-like growth factors and their binding proteins in fetal sheep. Am. J. Physiol. 263: E1151, 1992.
Hill D.J., Milner R.D.G. Insulin as a growth factor. Pediatr. Res. 19: 879, 1985.
Economides D.L., Nicolaides K.H., Campbell S. Metabolic and endocrine findings in appropriate and small for gestational age fetuses. J. Perinat. Med. 97: 195, 1991.
Hayek A., Driscoll S.G., Warshaw J.B. Endocrine studies in anencephaly. J. Clin. Invest. 52: 1636, 1973.
Mesiano S., Young I.R., Hey A.W., Browne C.A., Thorburn G.D. Hypophysectomy of the fetal lamb leads to a fall in the plasma concentration of insulin-like growth factor I (IGF-I), but not IGF-II Endocrinology 124: 1485, 1989.
Jewell D.E., Hausman G.J., Campion D.R. Fetal hypophysectomy causes a decrease in preadipocyte growth and insulin-like growth factor-I in pigs. Dom. Anim. Endocrinol. 6: 243, 1989.
Aubert M.L., Grumbach M.M., Kaplan S.L. The ontogenesis of human fetal hormones.III. Prolactin. J. Clin. Invest. 56: 155, 1975.
Parker C.R. Jr., MacDonald P.C., Guzick D.S., Porter J.C., Rosenfeld C.R., Hauth J.C. Prolactin levels in umbelical cord blood of human infants: relation to gestational age, maternal camplications, and neonatal lung function. Am. J. Obstet. Gynecol. 161: 795, 1989.
Thorpe-Beeston J.G., Snijders R.J., Felton C.V., Nicolaides K.H. Serum prolactin concentration in normal and small for gestational age fetuses. Br. J. Obstet. Gynecol. 99: 981, 1992.
Sinha Y.N., Klemcke H.G., Maurer R.R., Jacobsen B.P. Ontogeny of glycosylated and nonglycosylated forms of prolactin and growth hormone in porcine pituitary during fetal life. Proc. Soc. Exp. Biol. Med. 194: 293, 1990.
Sinha Y.N. Prolactin variants. Trends Endocrinol. Metab. 3: 100, 1992.
Brue T., Caruso E., Morange I., Hoffmann T., Evrin M., Gunz G., Benkirane M., Jaquet P. Immunoradiometric analysis of circulating human glycosylated and nonglycosylated prolactin forms: spontaneous and stimulated secretions. J. Clin. Endocrinol. Metab. 75: 1338, 1992.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Arosio, M., Cortelazzi, D., Persani, L. et al. Circulating levels of growth hormone, insulin-like growth factor-I and prolactin in normal, growth retarded and anencephalic human fetuses. J Endocrinol Invest 18, 346–353 (1995). https://doi.org/10.1007/BF03347836
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03347836